Ocugen, Inc. (OCGN) vs Palisade Bio, Inc. (PALI)
- Ocugen, Inc. OCGN 0.78 −3.70%
- Palisade Bio, Inc. PALI 1.41 −8.44%
Ocugen, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Ocugen, Inc. and Palisade Bio, Inc. are of similar size ($275.9M and $268.4M). Ocugen, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Palisade Bio, Inc. grew revenue faster over the last twelve months: 5,492.6% against −3.66%. Ocugen, Inc. has the higher net margin (−1,786.3% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Ocugen, Inc. leads on 9 and Palisade Bio, Inc. on 6.
Valuation
Profitability
| Metric | OCGN | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.63% | 65.16% |
| Operating margin | (1,504.43%) | (4,681.99%) | 0.00% |
| Net margin | (1,786.27%) | (4,230.60%) | 0.00% |
| Free cash flow margin | (1,332.36%) | (2,409.27%) | 0.00% |
| Return on equity | 1,211.66% | (51.37%) | (56.36%) |
| Return on assets | (92.03%) | (47.68%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack